Domains of delirium severity in Alzheimer's disease and related dementias.
ADRD
delirium
dementia
expert panel
instrument
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
11
11
2021
received:
14
09
2021
accepted:
01
12
2021
pubmed:
25
12
2021
medline:
18
5
2022
entrez:
24
12
2021
Statut:
ppublish
Résumé
The ability to rate delirium severity is key to providing optimal care for persons with Alzheimer's Disease and Related Dementias (ADRD). Such ratings would allow clinicians to assess response to treatment, recovery time and prognosis, nursing burden and staffing needs, and to provide nuanced, appropriate patient-centered care. Given the lack of existing tools, we defined content domains for a new delirium severity instrument for use in individuals with mild to moderate ADRD, the DEL-S-AD. We built upon our previous study in which we created a content domain framework to inform development of a general delirium severity instrument, the DEL-S. We engaged a new expert panel to discuss issues of measurement in delirium and dementia and to determine which content domains from the prior framework were useful in characterizing delirium severity in ADRD. We also asked panelists to identify new domains. Our panel included eight interdisciplinary members with expertise in delirium and dementia. Panelists participated in two rounds of review followed by two surveys over 2 months. Panelists endorsed the same content domains as for general delirium severity, including Cognitive, Level of Consciousness, Inattention, Psychiatric-Behavioral, Emotional Dysregulation, Psychomotor Features, and Functional; however, they excluded six of the original subdomains which they considered unhelpful in the context of ADRD: cognitive impairment; anxiety; fear/sense of unease; depression; gait/walking; and incontinence. Debated measurement challenges included assessment at one point in time versus over time, accounting for differences in clinical settings, and accurate assessment of symptoms related to delirium versus dementia. By capturing a range of characteristics of delirium severity potentially present in patients with ADRD, a population that may already have attention, functional, and emotional changes at baseline, the DEL-S-AD provides a novel rating tool that will be useful for clinical and research purposes to improve patient care.
Sections du résumé
BACKGROUND
The ability to rate delirium severity is key to providing optimal care for persons with Alzheimer's Disease and Related Dementias (ADRD). Such ratings would allow clinicians to assess response to treatment, recovery time and prognosis, nursing burden and staffing needs, and to provide nuanced, appropriate patient-centered care. Given the lack of existing tools, we defined content domains for a new delirium severity instrument for use in individuals with mild to moderate ADRD, the DEL-S-AD.
METHODS
We built upon our previous study in which we created a content domain framework to inform development of a general delirium severity instrument, the DEL-S. We engaged a new expert panel to discuss issues of measurement in delirium and dementia and to determine which content domains from the prior framework were useful in characterizing delirium severity in ADRD. We also asked panelists to identify new domains. Our panel included eight interdisciplinary members with expertise in delirium and dementia. Panelists participated in two rounds of review followed by two surveys over 2 months.
RESULTS
Panelists endorsed the same content domains as for general delirium severity, including Cognitive, Level of Consciousness, Inattention, Psychiatric-Behavioral, Emotional Dysregulation, Psychomotor Features, and Functional; however, they excluded six of the original subdomains which they considered unhelpful in the context of ADRD: cognitive impairment; anxiety; fear/sense of unease; depression; gait/walking; and incontinence. Debated measurement challenges included assessment at one point in time versus over time, accounting for differences in clinical settings, and accurate assessment of symptoms related to delirium versus dementia.
CONCLUSIONS
By capturing a range of characteristics of delirium severity potentially present in patients with ADRD, a population that may already have attention, functional, and emotional changes at baseline, the DEL-S-AD provides a novel rating tool that will be useful for clinical and research purposes to improve patient care.
Identifiants
pubmed: 34951704
doi: 10.1111/jgs.17624
pmc: PMC9106827
mid: NIHMS1763730
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1495-1503Subventions
Organisme : NIA NIH HHS
ID : K07 AG066813
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG044518
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG071744
Pays : United States
Informations de copyright
© 2021 The American Geriatrics Society.
Références
Ann Intern Med. 1990 Dec 15;113(12):941-8
pubmed: 2240918
J Am Geriatr Soc. 2002 Oct;50(10):1723-32
pubmed: 12366629
JAMA. 2017 Sep 26;318(12):1161-1174
pubmed: 28973626
Arch Intern Med. 2012 Sep 24;172(17):1324-31
pubmed: 23403619
BMJ. 2009 Feb 05;338:b75
pubmed: 19196746
Ann Intern Med. 2012 Jun 19;156(12):848-56, W296
pubmed: 22711077
Otolaryngol Head Neck Surg. 2015 Nov;153(2 Suppl):S1-S14
pubmed: 26527615
BMC Med Res Methodol. 2011 Dec 23;11:174
pubmed: 22196011
J Pain Symptom Manage. 1997 Mar;13(3):128-37
pubmed: 9114631
Lancet Neurol. 2015 Aug;14(8):823-832
pubmed: 26139023
Aust N Z J Psychiatry. 2015 Oct;49(10):887-97
pubmed: 26296368
Qual Life Res. 2019 Sep;28(9):2565-2578
pubmed: 31102155
Dement Geriatr Cogn Disord. 2020;49(1):77-90
pubmed: 32554974
Gerontology. 2019;65(1):20-29
pubmed: 30032141
Ann Intern Med. 2014 Apr 15;160(8):526-533
pubmed: 24733193